Research and Development
Asepsis Pharmaceuticals is a technology driven company investing over 20 percent of its annual revenue for the development, purchase and licensing of some of the most unique processes, products and therapeutic drugs in the world.
Research and Development
Asepsis is actively developing and formulating a pediatric injectable platform in three therapeutic areas:
- Anti-Infective
- Oncology
- Anesthesia
Parenteral Passive Safety
At Asepsis we believe the integration of science and ingenuity can reinvent some of the most important and widely used medicines and delivery devices. Our group is passionate about delivering creative products to eliminate complex and burdensome product administration for both patient and health care providers.
